
Tatva Chintan Pharma Chem Ltd. (TATVA) Chintan Pharma Chem Share Price near 52-week high after 5.27% rise
Updated: 21 Oct 2026 • 9:24 am
Posted by:

Tatva Chintan Pharma Chem Share Price was at Rs 2,000.10, up 5.27% today, and stayed close to its 52-week high. The company’s market capitalisation stood at Rs 4,444.61 crore as of 21 October 2026 at 9:22 AM IST.
Tatva Chintan Pharma Chem Share Price opened the session at Rs 2,015.10 and was last traded at Rs 2,000.10, up Rs 100.05 or 5.27% from the previous close of Rs 1,900.05. The move keeps Tatva Chintan Pharma Chem Share Price close to its 52-week high, with the day’s low at Rs 1,961.05 and the day’s high at Rs 2,109.95. The market capitalisation was Rs 4,444.61 crore, placing the company in focus across Tatva Chintan Pharma Chem Stock News and Tatva Chintan Pharma Chem Share Price Today searches.
Tatva Chintan Pharma Chem Share Price Today: Price Action Analysis
According to the latest Univest data, the price event is clear, but no company-specific catalyst is established from the numbers alone. That makes Tatva Chintan Pharma Chem Share Price relevant for readers tracking Tatva Chintan Pharma Chem Stock News, Tatva Chintan Pharma Chem Share News and Tatva Chintan Pharma Chem Latest News. The first question for investors is not whether the stock is active, but what the latest price, valuation and sector comparison show. On that front, Tatva Chintan Pharma Chem Share Price presents a high-valuation chemical-sector profile, with key financial ratios that stand out against the broader benchmark set.
| Metric | Value |
|---|---|
| Current Price | Rs 2,000.1 |
| Previous Close | Rs 1,900.05 |
| Today's Move | +Rs 100.05 (+5.27%) |
| Open | Rs 2,015.1 |
| High | Rs 2,109.95 |
| Low | Rs 1,961.05 |
| Market Capitalisation | Rs 4,444.61 crore |
Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 2,000.1 versus the previous close of Rs 1,900.05, a rise of 5.27%. The stock opened at Rs 2,015.1, reached a high of Rs 2,109.95 and touched a low of Rs 1,961.05.
Tatva Chintan Pharma Chem Share Price Today shows a session marked by a higher opening, a wide intraday band and a price that remained near the one-year high. The stock opened at Rs 2,015.10, moved between Rs 1,961.05 and Rs 2,109.95, and was last traded at Rs 2,000.10. The gap between the previous close of Rs 1,900.05 and the latest price was Rs 100.05, which equals 5.27% so far today. With the 52-week high at Rs 2,109.95, Tatva Chintan Pharma Chem Share Price was trading close to the top of its yearly range.
For readers following Tatva Chintan Pharma Chem Share Price Live and Tatva Chintan Pharma Chem Share Price Update, the key point is straightforward: the stock is positioned near its yearly high without any need to infer a separate reason from the numbers. Tatva Chintan Pharma Chem Stock Price action also reflects a session where the current price stayed above the previous close and within reach of the day’s high. For Tatva Chintan Pharma Chem Stock Analysis, the event is important because the stock is now one of the names appearing in 52 Week High Stocks and Stocks in News screens on Indian Stock Market watchlists.
The latest Univest figures therefore confirm a near-peak price event. They do not establish a company-specific trigger, but they do make Tatva Chintan Pharma Chem Share Price Today a live reference point for Share Market Today readers tracking Market Movers and Market News.
Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,444.61 crore |
| P/E Ratio | 70.64x |
| P/B Ratio | 5.46x |
| ROE | 5.53% |
| ROCE | 7.17% |
| EPS | Rs 26.9 |
| Book Value Per Share | Rs 348.26 |
| Dividend Yield | 0.11% |
Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P/E 70.64x, P/B 5.46x, ROE 5.53%, ROCE 7.17%. These figures provide context only and are not a buy or sell signal.
Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,444.61 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 70.64x, P/B at 5.46x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.9, book value per share of Rs 348.26, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.13x, median ROE of 8.1%, median ROCE of 10.36%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 70.64x |
| Benchmark Median P/E | 22.13x |
| Benchmark Average P/E | 43.4x |
| Benchmark P/E Range | 0x to 907.61x |
| Company P/B Ratio | 5.46x |
| Benchmark Median P/B | 1.84x |
| Company ROE | 5.53% |
| Benchmark Median ROE | 8.1% |
| Company ROCE | 7.17% |
| Benchmark Median ROCE | 10.36% |
| Company Market Capitalisation | Rs 4,444.61 crore |
| Benchmark Median Market Cap | Rs 454.94 crore |
Tatva Chintan Pharma Chem Ltd. (TATVA) is classified under sector: Chemicals and industry: Chemicals.
Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 70.64x, which is above the benchmark median of 22.13x, a difference of +219.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 8.1%, a difference of -31.73%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10.36%, a difference of -30.79%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Yasho Industries Ltd. | YASHO | 4,263.21 | 73.93 | 8.88 | 5.85 | 9.06 |
| Epigral Ltd. | EPIGRAL | 4,229.36 | 15.61 | 1.82 | 16.09 | 15.65 |
| Gujarat Alkalies And Chemicals Ltd. | GUJALKALI | 4,224.83 | 63.67 | 0.81 | -0.04 | 1.4 |
| Foseco India Ltd. | FOSECOIND | 4,698.24 | 64.99 | 4.35 | 10.87 | 15.35 |
| Laxmi Organic Industries Ltd. | LXCHEM | 4,762.07 | 37.89 | 2.35 | 4.13 | 4.7 |
Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 70.64x compared with the displayed peer median of 63.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.53% compares with a peer median of 5.85% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 9.06%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,444.61 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Tatva Chintan Pharma Chem
- Tatva Chintan Pharma Chem Share Price was at Rs 2,000.10, up 5.27% from the previous close of Rs 1,900.05.
- Tatva Chintan Pharma Chem Share Price remained close to the 52-week high during the session.
- Tatva Chintan Pharma Chem Market Cap stood at Rs 4,444.61 crore at the latest reading.
- Tatva Chintan Pharma Chem Share Price trades at a P/E of 70.64 and a P/B of 5.46.
- Tatva Chintan Pharma Chem Share Price sits below the sector median for ROE and ROCE, at 5.53% and 7.17%.
About Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Ltd. operates in the Chemicals sector and the Chemicals industry. The latest Univest reference point places Tatva Chintan Pharma Chem Share Price in an event-led update because the stock is trading near its 52-week high. The company’s reported financial references in this note include market cap, EPS, book value, dividend yield, ROE and ROCE. For readers searching Tatva Chintan Pharma Chem Company News, this profile is a factual snapshot of where the stock stands today.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Tatva Chintan Pharma Chem Share Price in focus today?
Ans. Tatva Chintan Pharma Chem Share Price is in focus because it was last traded at Rs 2,000.10, up 5.27% from the previous close. The stock also stayed near its 52-week high.
What is the current Tatva Chintan Pharma Chem Share Price?
Ans. Tatva Chintan Pharma Chem Share Price was Rs 2,000.10 in the latest reading. That level came after a rise of Rs 100.05 from the previous close of Rs 1,900.05, based on the latest Univest data.
How close is Tatva Chintan Pharma Chem Share Price to its 52-week high?
Ans. Tatva Chintan Pharma Chem Share Price was near its 52-week high. The gap between the latest price and that level remained limited, which keeps the yearly high in view for market participants.
What does Tatva Chintan Pharma Chem Fundamental Analysis show?
Ans. Tatva Chintan Pharma Chem Fundamental Analysis shows a P/E of 70.64, P/B of 5.46, ROE of 5.53% and ROCE of 7.17%. EPS is Rs 26.9, book value is Rs 348.26 and dividend yield is 0.11%.
How does Tatva Chintan Pharma Chem compare with its sector benchmark?
Ans. In the Chemicals benchmark set of 178 companies, Tatva Chintan Pharma Chem Share Price sits above the median on P/E and P/B, while ROE and ROCE remain below the benchmark medians. That gives a mixed valuation and return picture.
What is Tatva Chintan Pharma Chem Market Cap today?
Ans. Tatva Chintan Pharma Chem Market Cap stood at Rs 4,444.61 crore. Within the same-industry benchmark set, that places the company above the median market capitalisation and below the benchmark average.
How does Tatva Chintan Pharma Chem Share Price compare with peers?
Ans. Compared with peers such as Epigral, Laxmi Organic and Foseco India, Tatva Chintan Pharma Chem Share Price carries a richer P/E and P/B than several names, while its return ratios are lower than some of the listed comparables.
Where can I track Tatva Chintan Pharma Chem Share Price and Tatva Chintan Pharma Chem Stock News?
Ans. You can track Tatva Chintan Pharma Chem Share Price on Univest for live updates, key ratios, 52-week levels, sector comparison and Tatva Chintan Pharma Chem Stock News. It brings the latest reference points into one stock page.
Track Tatva Chintan Pharma Chem Share Price on Univest
Use Tatva Chintan Pharma Chem Ltd. (TATVA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Tatva Chintan Pharma Chem Share Price on Univest for live price updates, key financial ratios, market cap, 52-week levels, sector comparison and Tatva Chintan Pharma Chem Latest News. Univest also helps readers review Tatva Chintan Pharma Chem Fundamental Analysis, Tatva Chintan Pharma Chem Stock News and Tatva Chintan Pharma Chem Share Price Today in one place.
Recent Articles

Bitcoin Price Today on 12 November 2026: BTC Slips to $73,344 as Hot US Inflation, Fed Rate-Hike Bets and ETF Outflows Weigh on the Crypto Market
12 November 2026

Amicro Technology IPO Debut on 12 November 2026: Robot-Vacuum Chip Maker Touches HK$18.11 Intraday, Closes 38.2% Above Offer; Three Indian Robotics Stocks Explained
12 November 2026

Mahanadi Coalfields IPO Explained on 12 November 2026: SEBI Clears Coal India's 10% Offer for Sale Worth Up to $1 Billion, Launch Possible in Late November or Early December
12 November 2026

BofA Nifty Target Stays at 26,200 for December 2026: Hospitals and Telecom Upgraded, Two-Wheelers Turned Cautious as Nifty Trades Near 25,269 on 12 November 2026
12 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Bitcoin Price Today on 12 November 2026: BTC Slips to $73,344 as Hot US Inflation, Fed Rate-Hike Bets and ETF Outflows Weigh on the Crypto Market
Amicro Technology IPO Debut on 12 November 2026: Robot-Vacuum Chip Maker Touches HK$18.11 Intraday, Closes 38.2% Above Offer; Three Indian Robotics Stocks Explained
Mahanadi Coalfields IPO Explained on 12 November 2026: SEBI Clears Coal India's 10% Offer for Sale Worth Up to $1 Billion, Launch Possible in Late November or Early December
BofA Nifty Target Stays at 26,200 for December 2026: Hospitals and Telecom Upgraded, Two-Wheelers Turned Cautious as Nifty Trades Near 25,269 on 12 November 2026
IRFC Share Price Rises 10% in One Month to Rs 85 on 12 November 2026, but Is Still Down About 32% in 2026: Should You Buy After the Q2 FY27 Profit?
Popular this week
Rolex Rings Share Price Hits Year High of Rs 216.70, Up 118% From 52-Week Low: Q2 Profit Jumps 67% but Stock Looks Stretched

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





